GREENWICH LIFESCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.9M | $-5.7M | $-3.7M | $-3.7M | $-2.7M | $-2.7M | $-2.6M | $-2.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $1.5M | — | — | $1.5M | — | — | $594.5K |
| Net Cash from Operating Activities | $-1.9M | $-4.7M | $-2.7M | $-2.2M | $-1.8M | $-2.6M | $-1.0M | $-1.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $9.0M | — | — | $492.4K | — | — | $299.1K |
| Net Change in Cash | — | $4.3M | — | — | $-1.3M | — | — | $-1.5M |
| Free Cash Flow | — | — | — | — | — | — | — | — |